Price T Rowe Associates Inc United Therapeutics Corp Transaction History

Price T Rowe Associates Inc

$816 Billion
Q1 2024

A detailed history of Price T Rowe Associates Inc transactions in United Therapeutics Corp stock. As of the latest transaction made, Price T Rowe Associates Inc holds 26,976 shares of UTHR stock, worth $8.59 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

26,976

Previous 32,045 15.82%

Holding current value

$8.59 Million

Previous $7.05 Million 12.07%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$210.76 - $249.51 $1.07 Million - $1.26 Million	-5,069 Reduced 15.82%	26,976 $6.2 Million
Q4 2023 Feb 14, 2024	BUY	$214.88 - $256.94 $1.66 Million - $1.98 Million	7,704 Added 31.65%	32,045 $7.05 Million
Q3 2023 Nov 14, 2023	SELL	$211.82 - $248.24 $41,093 - $48,158	-194 Reduced 0.79%	24,341 $5.5 Million
Q2 2023 Aug 14, 2023	BUY	$205.19 - $232.99 $88,436 - $100,418	431 Added 1.79%	24,535 $5.42 Million
Q1 2023 May 15, 2023	BUY	$212.99 - $276.17 $126,942 - $164,597	596 Added 2.54%	24,104 $5.4 Million

Q4 2022 Feb 14, 2023	BUY	$205.95 - $280.43 $138,398 - $188,448	672 Added 2.94%	23,508 $6.54 Million
Q3 2022 Nov 14, 2022	SELL	$203.3 - $244.17 $22.4 Million - $26.8 Million	-109,938 Reduced 82.8%	22,836 $4.78 Million
Q2 2022 Aug 15, 2022	BUY	$174.81 - $241.14 $12.9 Million - $17.8 Million	73,913 Added 125.57%	132,774 $31.3 Million
Q1 2022 May 16, 2022	BUY	$166.16 - $213.96 $23,760 - $30,596	143 Added 0.24%	58,861 $10.6 Million
Q4 2021 Feb 14, 2022	SELL	$184.32 - $216.08 $279,429 - $327,577	-1,516 Reduced 2.52%	58,718 $12.7 Million
Q3 2021 Nov 15, 2021	SELL	$179.86 - $214.88 $183,637 - $219,392	-1,021 Reduced 1.67%	60,234 $11.1 Million
Q2 2021 Aug 16, 2021	SELL	$170.47 - $211.93 $49.9 Million - $62.1 Million	-292,869 Reduced 82.7%	61,255 $11 Million
Q1 2021 May 17, 2021	BUY	$153.94 - $174.85 $17 Million - $19.3 Million	110,623 Added 45.43%	354,124 $59.2 Million
Q4 2020 Feb 16, 2021	BUY	$101.87 - $151.79 $24.8 Million - $37 Million	243,501 New	243,501 $37 Million

Others Institutions Holding UTHR

# of Institutions

561

Shares Held

43.1M

Call Options Held

501K

Put Options Held

529K

View Full List

About UNITED THERAPEUTICS Corp

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $14.5B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

More about UTHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc United Therapeutics Corp Transaction History